P. De Sutter

发表

Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.

B. Neyns, W. Lissens, E. Teugels, 1995, Oncogene.

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

M. Lehtinen, D. Harper, S. Garland, 2013, The Journal of infectious diseases.

Clinical Performance of the RealTime High Risk HPV Assay on Self-Collected Vaginal Samples within the VALHUDES Framework

S. Weyers, M. Arbyn, G. Donders, 2022, Microbiology spectrum.

Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study.

S. Weyers, M. Arbyn, W. Tjalma, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases

B. Velkeniers, C. Bourgain, P. De Sutter, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Ex-vivo oocyte retrieval for fertility preservation.

P. Devroey, C. Bourgain, H. Fatemi, 2011, Fertility and sterility.

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.

C. Wheeler, H. Kitchener, M. Lehtinen, 2012, The Lancet. Oncology.

Detection of premalignant stages in cervical smears with a biotinylated probe for chromosome 1.

M. Kirsch‐Volders, P. van Dam, S. Haesen, 1994, Cancer genetics and cytogenetics.

Successful Primary Treatment of a Hydatidiform Mole with Methotrexate and EMA/CO

C. Fontaine, M. De Vos, P. de Sutter, 2009, Case reports in medicine.

A persistently recurring peri-urethral soft tissue lesion of the vulva.

C. Bourgain, D. Michielsen, J. Amy, 2005, Pathology, research and practice.

Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial

C. Wheeler, H. Kitchener, M. Lehtinen, 2015, Clinical and Vaccine Immunology.

Endocrine Treatment and Prevention of Breast and Gynecological Cancers Vth International Symposium of the Flemish Gynecological Oncology Group, January 26-28, 2006.

P. Neven, I. Vergote, F. Amant, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

The oestrogen receptor and its selective modulators in gynaecological and breast cancer.

P. Neven, I. Vergote, P. van Dam, 2000, European journal of cancer.

Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis

Joris Meys, M. Temmerman, H. Verstraelen, 2011, BMC infectious diseases.

Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor.

W. Lissens, J. De Grève, C. Bourgain, 1992, Cancer research.

Association between Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Systematic Review and Meta-Analysis

Joris Meys, M. Temmerman, H. Verstraelen, 2012, PloS one.

Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.

J. Doyen, S. Weyers, M. Arbyn, 2021, Gynecologic oncology.

Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study

J. Doyen, S. Weyers, M. Arbyn, 2021, Archives of Public Health.

GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: a case report.

J. Amy, H. Fatemi, P. De Sutter, 2005, Gynecologic oncology.

Invasive Recurrence of an Intestinal-Type Mucinous Epithelial Neoplasm of Low Malignant Potential: Case Report and Review of the Literature

C. Bourgain, P. De Sutter, P. Sutter, 2011, Case Reports in Oncology.

Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA‐PCR testing and cervicography

M. Temmerman, J. Bwayo, H De Vuyst, 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.

M. Poljak, W. Tjalma, S. Weyers, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.

C. Bourgain, J. Amy, M. Breugelmans, 2004, Gynecologic oncology.

Is there a role for cervicography in the detection of premalignant lesions of the cervix uteri?

D. Hertens, M. Vosse, M. Coibion, 1994, British Journal of Cancer.

Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor.

P. Devroey, E. Papanikolaou, H. Al-Turki, 2005, Reproductive Biomedicine Online.

Vaginal Cuff Dehiscence: Two Case Reports and a Review of the Literature

P. De Sutter, Babette Jaime Moens, Antonino Buonomo, 2023, Journal of clinical medicine.

Validation of BD Onclarity HPV assay on vaginal self-samples versus cervical samples using the VALHUDES protocol.

S. Weyers, M. Arbyn, W. Tjalma, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

H. Kitchener, M. Lehtinen, S. Garland, 2015, Clinical and Vaccine Immunology.